H1F0 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.533000E-01
Normal-vs-Stage2
1.888160E-01
Normal-vs-Stage3
6.862400E-01
Normal-vs-Stage4
2.783200E-01
Stage1-vs-Stage2
3.585400E-01
Stage1-vs-Stage3
8.408800E-01
Stage1-vs-Stage4
3.359600E-01
Stage2-vs-Stage3
3.266800E-01
Stage2-vs-Stage4
5.071800E-01
Stage3-vs-Stage4
3.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.247000E-01
Normal-vs-AfricanAmerican
3.046600E-01
Normal-vs-Asian
1.196000E-01
Caucasian-vs-AfricanAmerican
5.733400E-01
Caucasian-vs-Asian
9.961000E-01
AfricanAmerican-vs-Asian
6.894200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.870240E-01
Normal-vs-Female
2.565200E-01
Male-vs-Female
9.946800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.539200E-01
Normal-vs-Age(41-60Yrs)
1.970580E-01
Normal-vs-Age(61-80Yrs)
2.163000E-01
Normal-vs-Age(81-100Yrs)
3.666600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.249400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.492800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.190200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.363000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.721650E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.046450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.744000E-01
Normal-vs-Daily Drinker
2.125400E-01
Normal-vs-Weekly Drinker
1.903970E-01
Normal-vs-Occasional Drinker
1.108650E-01
Normal-vs-Social Drinker
2.269800E-01
Non Drinker-vs-Daily Drinker
3.525800E-01
Non Drinker-vs-Weekly Drinker
7.546800E-01
Non Drinker-vs-Occasional Drinker
6.795500E-02
Non Drinker-vs-Social Drinker
7.899000E-01
Daily Drinker-vs-Weekly Drinker
6.111200E-01
Daily Drinker-vs-Occasional Drinker
4.180800E-01
Daily Drinker-vs-Social Drinker
5.836000E-01
Weekly Drinker-vs-Occasional Drinker
1.983590E-01
Weekly Drinker-vs-Social Drinker
9.664000E-01
Occasional Drinker-vs-Social Drinker
1.862230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.427600E-01
Normal-vs-Grade 2
9.155900E-02
Normal-vs-Grade 3
3.285500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.258000E-02
Grade 1-vs-Grade 3
4.677100E-03
Grade 1-vs-Grade 4
2.427600E-01
Grade 2-vs-Grade 3
1.002410E-01
Grade 2-vs-Grade 4
9.155900E-02
Grade 3-vs-Grade 4
3.285500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.068200E-01
Normal-vs-NonDiabetic
1.617790E-01
Diabetic-vs-NonDiabetic
3.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.612500E-02
Normal-vs-NoPancreatitis
2.296600E-01
Pancreatitis-vs-NoPancreatitis
4.415600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.963790E-01
Normal-vs-N1
2.008000E-01
N0-vs-N1
4.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.463700E-02
Normal-vs-TP53-NonMutant
5.362600E-01
TP53-Mutant-vs-TP53-NonMutant
6.24899998413753E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
